{"acute kidney injury": 3.38, "acute myeloid leukaemia": 22.03, "adverse event": 31.0, "aspartate aminotransferase increased": 2.15, "aspergillus infection": 30.96, "bradycardia": 2.89, "bronchopulmonary aspergillosis": 37.73, "cardiac arrest": 2.68, "cholestasis": 19.74, "death": 6.69, "drug interaction": 7.07, "drug intolerance": 2.0, "drug level below therapeutic": 53.06, "drug level decreased": 44.61, "drug level increased": 19.93, "drug-induced liver injury": 15.69, "electrocardiogram qt prolonged": 20.51, "febrile neutropenia": 3.42, "fungal infection": 8.37, "gamma-glutamyltransferase increased": 5.29, "graft versus host disease": 30.45, "hepatic cytolysis": 21.63, "hepatic enzyme increased": 4.66, "hepatic function abnormal": 4.61, "hepatotoxicity": 10.52, "hyperbilirubinaemia": 14.56, "hypokalaemia": 53.15, "inappropriate schedule of product administration": 2.21, "incorrect dose administered": 6.33, "infection": 2.59, "leukaemia": 26.36, "liver injury": 7.24, "myelodysplastic syndrome": 9.19, "overdose": 3.58, "pancytopenia": 2.15, "pneumonia fungal": 55.0, "product prescribing error": 13.74, "product use in unapproved indication": 6.62, "product use issue": 6.65, "rash maculo-papular": 7.49, "renal failure": 2.11, "renal impairment": 2.48, "respiratory failure": 2.15, "rhabdomyolysis": 4.12, "sepsis": 3.03, "septic shock": 4.2, "therapeutic product ineffective": 47.92}